Abstract
Purpose of Review
This paper examines the overlap of conversion disorder with chronic pain conditions, describes ways to assess for conversion disorder, and provides an overview of evidence-based treatments for conversion disorder and chronic pain, with a focus on conversion symptoms.
Recent Findings
Conversion disorder is a significant problem that warrants further study, given that there are not many well-established guidelines. Accurate and timely assessment should help move treatment in a more fruitful direction and avoid unnecessary medical interventions. Advances in neuroimaging may also help further our understanding of conversion disorder. Creating a supportive environment and a collaborative treatment relationship and improving understanding of conversion symptoms appear to help individuals diagnosed with conversion disorder engage in appropriate treatments. Novel uses of earlier treatments, such as hypnosis and psychodynamic approaches, could potentially be beneficial and require a more vigorous and systematic study.
Summary
There are treatments that produce significant improvements in functioning and reduction of physical symptoms from conversion disorder even for very severe cases. Hypnotherapy, cognitive behavioral therapy, and inpatient multidisciplinary treatment with intensive physiotherapy for severe cases have the most evidence to support reduction of symptoms. Components of treatment for conversion disorder overlap with treatments for chronic pain and can be used together to produce therapeutic effects for both conditions. Treatment needs to be tailored for each individual’s specific symptoms.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth ed. Arlington: American Psychiatric Association; 2013.
National Organization for Rare Disorders. Conversion disorder [Internet]. Rare disease information; 2016 [updated: 2003] Available from: https://rarediseases.org/rare-diseases/conversion-disorder/
Nowack WJ. Epilepsy: a costly misdiagnosis. Clin Electroencephalogr. 1997;28:225–8.
Stone J, Binzer M, Sharpe M. Illness beliefs and locus of control: a comparison of patients with pseudoseizures and epilepsy. J Psychosom Res. 2004;57:541–7.
Parisod E, Murray RF, Cousins MJ. Conversion disorder after implant of a spinal cord stimulator in a patient with a complex regional pain syndrome. Anasthesia & Analgesia. 2003;96:201–6.
Shiri S, Tsenter J, Livai I, Vatine J. Similarities between the psychological profiles of complex regional pain syndrome and conversion disorder patients. J Clin Psychol Med Settings. 2003;10(3):193–9.
Gazzola DM, Carlson C, Rugino A, Hirsch S, Starner K, Devinsky O. Psychogenic nonepileptic seizures and chronic pain: a retrospective case-controlled study. Epilepsy Behav. 2012;25:662–5.
Kozlowska K, Nunn KP, Rose D, Morris A, Ouvrier RA, Varghese J. Conversion disorder in Australian pediatric practice. Journal of American Academy of Adolescent Psychiatry. 2007;46(1):68–75.
Shepard MA, Silva A, Starling AJ, Hoerth MT, Locke DC, Ziemba K et al. Patients with psychogenic nonepileptic seizures report more severe migraine than patients with epilepsy. Seizure. 2016;3478–3482.
Benbadis SR. A spell in the epilepsy clinic and a history of “chronic pain” or “fibromyalgia” independently predict a diagnosis of psychogenic seizures. Epilepsy Behav. 2005;6:264–5.
Dixit R, Popescu A, Bagic A, Ghearing G, Hendrickson R. Medical comorbidities in patients with nonepileptic spells (PNES) referred for video-EEG monitoring. Epilepsy Behav. 2013;28:137–40.
• Stone J, Warlow C, Sharpe M. The symptom of functional weakness: a controlled study of 107 patients. Brain. 2010;133:1537–51. As one of the few controlled studies of symptoms of conversion disorder, the study is able to provide clinicians and researchers with helpful information regarding associated features and information to consider regarding differential diagnosis.
Ettinger AB, Devinksy O, Weisbrot DM, Goyal A, Shashikumar S. Headaches and other pain symptoms among patients with psychogenic nonepileptic seizures. Seizure. 1999;8:424–6.
Zhang YC, Bromfield EB, Hurwitz S, Nelson A, Sylvia K, Dworetsky BA. Comparison of outcomes of video/EEG monitoring between patients with epileptic seizures and those with psychogenic nonepileptic seizures. Epilepsy Behav. 2009;15(3):303–7.
Elliott JO, Charyton C. Biopsychosocial predictors of psychogenic nonepileptic seizures. Epilepsy Res. 2014;108:1543–55.
Marquez AV, Farias ST, Apperson M, Koopmans S, Jorgensen J, Shatzel A, Alsaadi TM. Psychogenic nonepileptic seizures are associated with an increased risk of obesity. Epilepsy Behav. 2004;5:88–93.
Tojek TM, Lumley M, Barkley G, Mahr G, Thomas A. Stress and other psychosocial characteristics of patients with psychogenic nonepileptic seizures. Psychosomatics. 2000;41:221–6.
de Wat CJ, Mellers JD, Gardner WN, Toone BK. Pseudoseizures and asthma. J Neurol Neurosurg Psychiatry. 2003;74:639–41.
Stone J. Functional neurological symptoms. J R Coll Physicians Edinb. 2011;41(1):38–41.
• Stone J, Carson A. Functional neurological symptoms: assessment and management. Neurol Clin. 2011;29(1):1–18. It is an excellent review article that provides a good overview of positive clinical neurological signs that suggest conversion disorder.
Tremolizzo L, Susani E, Riva MA, Cesana G, Ferrarese C, Appollonio I. Positive signs of functional weakness. J Neurol Sci. 2014;340(1–2):13–8.
Sonoo M. Abductor sign: a reliable new sign to detect unilateral non-organic paresis of the lower limb. J Neurol Neurosurg Psychiatry. 2004;75:121–5.
Stone J, Carson A. Functional neurologic disorders. Continuum (Minneap Minn). 2015;21:818–37.
Lombardi TL, Barton E, Wang J, Eliashiv DS, Chung JM, Muthukumaran A, et al. The elbow flex-ex: a new sign to detect unilateral upper extremity non-organic paresis. J Neurol Neurosurg Psychiatry. 2014;85:165–7.
•• Ejareh Dar M, Kanaan RAA. Uncovering the etiology of conversion disorder: insights from functional neuroimaging. Neuropsychiatr Dis Treat. 2016;12:143–53. It is a great review article highlighting all the major functional imaging studies of conversion disorder and the corresponding anatomic areas involved in conversion disorder.
Aybek S, Vuilleumier P. Imaging studies of functional neurological disorders. Handb Clin Neurol. 2017;139:73–84.
Voon V, Brezing C, Gallea C, Hallett M. Aberrant supplementary motor complex and limbic activity during motor preparation in motor conversion disorder. Mov Disord. 2011;26(13):2396–403.
Voon V, Gallea C, Hattori N, Bruno M, Ekanayake V, Hallett M. The involuntary nature of conversion disorder. Neurology. 2010;74(3):223–8.
Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010;133:1526–36.
Yaźići KM, Kostakoglu L. Cerebral blood flow changes in patients with conversion disorder. Psychiatry Res. 1998;83(3):163–8.
Aybek S, Nicholson TR, Zelaya F, et al. Neural correlates of recall of life events in conversion disorder. JAMA psychiatry. 2014;71(1):52–60.
Aybek S, Nicholson TR, O’Daly O, Zelaya F, Kanaan RA, David AS. Emotion-motion interactions in conversion disorder: an FMRI study. PLoS One. 2015;10(4):e0123273.
Graham JR. MMPI-2: assessing personality and psychopathology. New York: Oxford University Press; 2006.
Spitzer RL, Williams JBW, Kroenke K, Linzer M, deGruy IIIFV, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749–56.
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282:1737–44.
Spitzer RL, Williams JBW, Kroenke K, Hornyak R, McMurray J. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric–gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics–Gynecology Study. Am J Obstet Gynecol. 2000;183:759–69.
Korber S, Frieser D, Steinbrecher N, Hiller W. Classification characteristics of the Patient Health Questionnaire-15 for screening somatoform disorders in a primary care setting. J Psychosom Res. 2011;71:142–7.
Moene FC, Spinhoven P, Hoogduin KAL, vanDyck R. A randomized controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for inpatients with conversion disorder of the motor type. Psychother Psychosom. 2002;71:66–76.
LaFrance WC, Miller IW, Ryan CE, Blum AS, Solomon DA, Kelley JE, et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009;14:591–6.
Goldstein LH, Chalder T, Chigwedere C, Khondoker MR, Moriarty J, Toone BK, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010;74:1986–94.
Kuyk J, Siffels MC, Badkvis P, Swinels WAM. Psychological treatment of patients with psychogenic nonepileptic seizures: an outcome study. Seizure. 2008;17:595–603.
•• McCormack R, Moriarty J, Mellers JD, Shotbolt P, Pastena R, Landes N, Goldstein L, Fleminger S, David AS. Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study. J Neurol Neurosurg Psychiatry. 2014;85:893–8. This is one of the few contemporary studies demonstrating the effectiveness of a comprehensive multimodal program for the treatment of severe conversion disorder. This approach bears a similarity to multidisciplinary and interdisciplinary treatment of chronic pain.
Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66.
Ataoglu A, Ozcetin A, Icmeli C, Ozbulut O. Paradoxical therapy in conversion reaction. J Korean Med Sci. 2003;18:581–4.
Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in thte treatment of functional (conversion) neurological symptoms. J Neurol Neurosurg Psychiatry. 2014;85:191–7.
Goldstein LH, Deale AC, Mitchell O’Malley S, Toone BK, Mellers JDC. An evaluation of cognitive behavioral therapy as a treatment for dissociative seizures: a pilot study. Cog Behav Neurol. 2004;17(1):41–9.
Lang EV. Patient sedation without medication: rapid rapport and quick hypnotic techniques a resource guide for doctors, nurses, and technologists. 1st ed. Seattle: Create Space Independent Publishing Platform; 2009.
Patterson DR. Clinical hypnosis for pain control. 1st ed. Washington D.C.: American Psychological Association; 2010.
Lang EV, Berbaum KS, Faintuch S, Hatsiopoulou O, Halsey N, Li X, et al. Adjunctive self-hypnotic relaxation for outpatient medical procedures: a prospective randomized trial with women undergoing large core breast biopsy. Pain. 2006;126:155–64.
Patterson DR, Jensen MP. Hypnosis and clinical pain. Psychol Bull. 2003;129(4):495–521.
Moene FC, Spinhoven P, Hoogduin KAL, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn. 2003;51(1):29–50.
Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79:282–4.
Barry JJ, Witenberg D, Bullock KD, Michaels JB, Classen CC, Risher RS. Group therapy for patients with psychogenic nonepileptic siezures: a pilot study. Epilepsy ad Behavior. 2008;13:624–9.
Harden RN, Oaklander AL, Burton AW, Perez RSGM, Richardson K, Swan M, Barthel J, Costa B, Graciosa JR, Bruehl S. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med. 2013;14(2):180–229.
Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006;166:1512–8.
Acknowledgements
The authors would like to thank Dr. Christopher Robin Page for editing this paper and providing valuable feedback.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Patricia Tsui, Andrew Deptula, and Derek Y. Yuan declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Psychological and Behavioral Aspects of Headache and Pain
Rights and permissions
About this article
Cite this article
Tsui, P., Deptula, A. & Yuan, D.Y. Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment. Curr Pain Headache Rep 21, 29 (2017). https://doi.org/10.1007/s11916-017-0627-7
Published:
DOI: https://doi.org/10.1007/s11916-017-0627-7